Patient-Derived Tumor Organoid Drug Development Platform Launched
October 17, 2019 08:39 ET
|
Crown Bioscience
SAN DIEGO, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience today announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the...
SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform
October 02, 2019 09:00 ET
|
SEngine Precision Medicine
SEATTLE, Wash., Oct. 02, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its CLIA certified, proprietary diagnostic platform...
CrownBio and Hubrecht Organoid Technology Announce a Strategic Partnership, including Exclusive License to Provide Oncology Organoid-Based Preclinical Drug Development and Validation Services
March 27, 2019 08:00 ET
|
Crown Bioscience
SAN DIEGO, March 27, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation and...